Evidence map›Paper›PMID 41430211›Full record

ReviewThe Korean journal of internal medicine2026

Clinical management of gastric mucosa-associated lymphoid tissue lymphoma.

Ji Yong Ahn

Abstract readReview
In one paragraph

Review in The Korean journal of internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ji Yong AhnDepartment of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is often associated with chronic Helicobacter pylori infection. For an accurate diagnosis of gastric MALT lymphoma, clinical suspicion and careful endoscopic examination with multiple biopsies should be performed, and the final pathological confirmation should be provided. Gastric MALT lymphomas present with nonspecific symptoms and endoscopic findings. In most cases, H. pylori infection is the main cause of gastric MALT lymphoma. Therefore, H. pylori eradication should be considered the first-line treatment, even in cases of H. pylori-negative gastric MALT lymphoma. Radiotherapy or chemotherapy can be considered in patients in whom eradication therapy has failed. Because the clinical course of gastric MALT lymphoma is usually indolent, the "watch-and-wait" strategy is one of the choices for selected patients who can undergo scheduled regular follow-up examination.

Indexed as

Helicobacter InfectionsLymphoma, B-Cell, Marginal ZoneStomach NeoplasmsAnti-Bacterial AgentsBiopsyGastroscopyHelicobacter pyloriHumansPredictive Value of TestsRisk FactorsTreatment OutcomeWatchful WaitingAnti-Bacterial AgentsHelicobacter pyloriLymphomaStomach

Identifiers

PMID41430211
PMCPMC12800460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.